跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
利卓瑞 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Molnupiravir Capsules
Approved
化学药品
Molnupiravir Capsules
MERCK SHARP & DOHME (UK) LIMITED
🇨🇳 National Medical Products Administration
Approval Date
Apr 21, 2025
Approval ID
5d904ae41a2a3eb9
Company
MERCK SHARP & DOHME (UK) LIMITED
Type
化学药品
Approval Details
Approval Id
5d904ae41a2a3eb9
Approval Number
国药准字HJ20220097
Generic Name
莫诺拉韦胶囊
Generic Name En
Molnupiravir Capsules
Trade Name
利卓瑞
Drug Type
化学药品
Dosage Form
胶囊剂
Strength
0.2g
Reg Date
2025-04-21
Expired Date
2027-12-28
Company Name
MERCK SHARP & DOHME (UK) LIMITED
Company Detail Path
/organization/merck-sharp-and-dohme-uk-limited
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Apr 21, 2025
Approval ID
5d904ae41a2a3eb9
Type
化学药品
Back to NMPA Approvals